HHLR Advisors’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $550K | Hold |
76,247
| – | – | 0.02% | 33 |
|
|
2025
Q1 | $629K | Hold |
76,247
| – | – | 0.02% | 44 |
|
|
2024
Q4 | $3.04M | Hold |
76,247
| – | – | 0.11% | 26 |
|
|
2024
Q3 | $660K | Sell |
76,247
-48,621
| -39% | -$421K | 0.01% | 44 |
|
|
2024
Q2 | $1.09M | Buy |
124,868
+48,620
| +64% | +$425K | 0.03% | 70 |
|
|
2024
Q1 | $1.87M | Hold |
76,248
| – | – | 0.04% | 51 |
|
|
2023
Q4 | $1.27M | Sell |
76,248
-16,143
| -17% | -$268K | 0.03% | 42 |
|
|
2023
Q3 | $1.73M | Hold |
92,391
| – | – | 0.04% | 51 |
|
|
2023
Q2 | $2.24M | Hold |
92,391
| – | – | 0.05% | 49 |
|
|
2023
Q1 | $2.02M | Hold |
92,391
| – | – | 0.04% | 61 |
|
|
2022
Q4 | $2.2M | Sell |
92,391
-2,212
| -2% | -$52.7K | 0.05% | 57 |
|
|
2022
Q3 | $2.6M | Hold |
94,603
| – | – | 0.07% | 49 |
|
|
2022
Q2 | $2.86M | Hold |
94,603
| – | – | 0.06% | 54 |
|
|
2022
Q1 | $5.09M | Hold |
94,603
| – | – | 0.11% | 44 |
|
|
2021
Q4 | $28.1M | Hold |
94,603
| – | – | 0.43% | 32 |
|
|
2021
Q3 | $36.7M | Buy |
94,603
+8,000
| +9% | +$3.1M | 0.48% | 31 |
|
|
2021
Q2 | $44.1M | Hold |
86,603
| – | – | 0.45% | 33 |
|
|
2021
Q1 | $49.2M | Hold |
86,603
| – | – | 0.49% | 30 |
|
|
2020
Q4 | $59.9M | Buy |
+86,603
| New | +$59.9M | 0.48% | 30 |
|